Throughout the Allerton III Conference, several consistent research needs were identified across scientific disciplines. First, additional basic research is needed to identify genomic mechanisms and novel genes/proteins in a variety of tissues under different conditions. Second, expansion of the infrastructure of the scientific community is needed. This can best be accomplished by additional competitive grants programs for training grants, program project grants, and multidisciplinary research projects. Third, the need for improved tools for animal bioinformatics was emphasized. Fourth, competitive grants programs for extension/outreach efforts and application of genomic technologies to production systems are needed. Finally, efforts to publicize and document the benefits of animal genomics for improved human health and animal production systems to members of Congress and the general public should be enhanced.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1081/ABIO-120022137 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research.
EBioMedicine
December 2024
Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Gastroenterology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. Electronic address:
Article Synopsis
- Large-scale studies are essential to investigate the gut microbiota's complex relationships with health and disease, and tissue preservation methods need evaluation for feasibility in such research.
- Biopsies from 20 adults with inflammatory bowel disease were preserved using three methods: flash freezing, nucleic acid preservative reagents, and formalin fixation with paraffin embedding (FFPE), with microbiota analyzed using sequencing.
- Results showed that while preservative reagents can serve as viable alternatives to flash freezing, FFPE samples exhibited distinct community structures, highlighting the potential utility of historical samples despite differences in microbial profiles.
ENOVAT: the European Network for Optimization of Veterinary Antimicrobial Treatment.
Open Res Eur
September 2024
Department of Biomolecular Health Sciences, Utrecht University, Utrecht, 3584 CL, The Netherlands.
Article Synopsis
- The global antimicrobial resistance crisis has prompted international efforts to improve antimicrobial stewardship in the veterinary sector, facing challenges like expert shortages and lack of treatment guidelines.
- Surveys and research initiated by the COST Action ENOVAT aim to address these issues by exploring current practices and improving diagnostics.
- The white paper emphasizes the need for a sustainable European veterinary research agenda to ensure long-term improvements in antimicrobial use and resistance management.
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level.
Lancet Rheumatol
August 2023
IRCCS Ospedale Galeazzi - Sant'Ambrogio, Rheumatology Department, Milan, Italy. Electronic address:
Background: The Calcium Pyrophosphate Deposition (CPPD) subgroup of the Outcome Measures in Rheumatology (OMERACT) Ultrasound working group was established to validate ultrasound as an outcome measure instrument for CPPD, and in 2017 has developed and validated standardised definitions for elementary lesions for the detection of calcium pyrophosphate crystals in joints. The aim of this study was to develop and evaluate the reliability of a consensus-based ultrasound scoring system for CPPD extent, representing the next phase in the OMERACT methodology.
Methods: In this study the novel scoring system for CPPD was developed through a stepwise process, following an established OMERACT ultrasound methodology.
Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs).
Joint Bone Spine
March 2024
Service de rhumatologie, centre national de référence maladies rares Est Sud-Ouest (RESO), hôpitaux universitaires de Strasbourg, université de Strasbourg, 1, avenue Molière, 67200 Strasbourg, France. Electronic address:
The improved understanding of the molecular basis of innate immunity have led to the identification of type I interferons (IFNs), particularly IFN-α, as central mediators in the pathogenesis of several Immune-mediated inflammatory diseases (IMIDs) such as systemic lupus erythematosus (SLE), systemic sclerosis, inflammatory myositis and Sjögren's syndrome. Here, we review the main data regarding the opportunity to target type I IFNs for the treatment of IMIDs. Type I IFNs and their downstream pathways can be targeted pharmacologically in several manners.
View Article and Find Full Text PDFTrends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe.
JAMA Dermatol
March 2023
Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, Erlangen, Germany.
Article Synopsis
- * Data was collected from several databases and showed that while positivity rates for MCI/MI have decreased in Europe, they have continued to rise in North America, especially for MI.
- * The differing trends in reactions could be linked to earlier and stricter regulations on MI in Europe compared to North America.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!